26.54
Finanzdaten der Vtv Therapeutics Inc-Aktie (VTVT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
36.84 | - | - | - |
| Operating Expenses |
2.61%
13.93
|
13.58 | 7.885 | 10.70 | 7.721 |
| Operating Income/Loss |
159.88%
-13.93
|
23.26 | -7.885 | -10.70 | -7.721 |
| Income/Loss From Continuing Operations Before Tax |
154.09%
-13.05
|
24.13 | -7.138 | -10.35 | -7.38 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
|
|
154.09%
-13.05
|
24.13 | -7.138 | -10.35 | -7.38 |
| Attributable To Noncontrolling Interest |
-
|
- | - | -1.647 | -1.334 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):